跳至主要内容
临床试验/NCT05291325
NCT05291325已完成不适用

Application of Linaclotide Capsule in Bowel Preparation for Colonoscopy: a Multicenter, Randomized, Controlled Clinical Study

Changhai Hospital1 个研究点 分布在 1 个国家目标入组 1,607 人开始时间: 2022年5月25日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
1,607
试验地点
1
主要终点
Bowel preparation adequate rate

研究概览

简要总结

The clinical purpose of this study was to investigate whether the adjuvant application of linaclotide in bowel preparation for colonoscopy could improve the quality of bowel preparation or reduce the dosage of laxatives.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-75 years old, male or female;
  • To undergo diagnostic, screening or monitoring colonoscopy;
  • Signed written informed consent;

排除标准

  • Severe cardiopulmonary insufficiency, renal failure or a history of stroke or myocardial infarction within six months;
  • History of abdominal or pelvic surgery;
  • Pregnant and lactating women;
  • BMI > 28, BMI < 18.5, inflammatory bowel disease, constipation (defecation less than 3 times in the last week, and laborious defecation, fecal sclerosis, low volume) or intestinal obstruction and other high-risk factors of intestinal preparation;
  • Abnormal coagulation function or taking antiplatelet or anticoagulant drugs within 7 days;
  • Warning symptoms and signs of colorectal cancer: hematochezia, melena, unexplained anemia, low body weight, abdominal mass, positive digital rectal test; or imaging and laboratory tests highly suspect colorectal cancer;
  • Colon polyps have been identified;
  • Stow score 7 (watery, no solid mass), diarrhea was considered;
  • Participation in other interventional clinical trials within 60 days.

研究组 & 干预措施

3L PEG + Linaclotide

Experimental

Bowel preparation for colonoscopy was performed with 3L polyethylene glycol solution combined with 3-day linaclotide.

干预措施: 3L PEG + Linaclotide (Drug)

3L PEG alone

Active Comparator

Bowel preparation for colonoscopy was performed with 3L polyethylene glycol solution without linaclotide.

干预措施: 3L PEG (Drug)

2L PEG + Linaclotide

Experimental

Bowel preparation for colonoscopy was performed with 2L polyethylene glycol solution combined with 3-day linaclotide.

干预措施: 2L PEG + Linaclotide (Drug)

结局指标

主要结局

Bowel preparation adequate rate

时间窗: within 10 minute after viewing colonoscopy video.

The proportion of participants with all colon segment scores (right colon, transverse colon, left colon) were ≥ 2 according to Boston Bowel Preparation Scale (BBPS) .

次要结局

  • Boston bowel preparation scale score(Within 10 minute after viewing colonoscopy video.)
  • Endoscopists satisfaction with the quality of bowel preparation(Immediately after colonoscopy.)
  • Bowel preparation excellent rate(Within 10 minute after viewing colonoscopy video.)
  • Bowel preparation completion rate assessed by questionnaire survey(Immediately after questionnaire survey.)
  • Subjects satisfaction rate assessed by questionnaire survey(Immediately after questionnaire survey.)
  • Polyp detection rate(Immediately after colonoscopy.)
  • Incidence of adverse events assessed by questionnaire survey(Immediately after questionnaire survey.)
  • Adenoma detection rate(14 days after colonosopy.)
  • Drug compliance in linaclotide group(Immediately after questionnaire survey.)
  • Aronchick Scale(Within 10 minute after viewing colonoscopy video.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhaoshen Li

Professor

Changhai Hospital

研究点 (1)

Loading locations...

相似试验